Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Threshold in Focus—Defining Amyloid Positivity on the Centiloid Scale. Local targets link to admitted publications; unresolved targets remain external evidence.
Updated appropriate use criteria for amyloid and tau PET.
10.1002/alz.078912 · 2023 · External reference
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-ß plaques: a prospective cohort study.
10.1016/s1474-4422(12)70142-4 · 2012 · External reference
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease: phase 3 study.
10.1016/j.jalz.2015.02.004 · 2015 · External reference
Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer’s disease.
10.1016/j.dadm.2017.06.001 · 2017 · External reference
Stress testing the Centiloid: precision and variability of PET quantification of amyloid pathology.
10.1002/alz.13883 · 2024 · External reference
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
10.1016/j.jalz.2014.07.003 · 2015 · External reference
A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research.
10.1016/j.nicl.2025.103765 · 2025 · External reference
Quantification supports amyloid PET visual assessment of challenging cases: results from the AMYPAD diagnostic and patient management study.
10.2967/jnumed.124.268119 · 2025 · External reference
10.1001/jama.2026.13116 · 2026 · Admitted local publication
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.
10.1002/alz.14336 · 2024 · External reference
Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease.
10.1186/s13195-020-00587-5 · 2020 · External reference
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer’s disease neuropathology.
10.1016/j.jalz.2018.09.001 · 2019 · External reference
Concordance between amyloid-PET quantification and real-world visual reads.
10.1001/jamaneurol.2025.2218 · 2025 · External reference
Characterizing amyloid-positive individuals with normal tau PET levels after 5 years: an ADNI study.
10.1212/wnl.0000000000200287 · 2022 · External reference
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies.
10.1002/alz.70997 · 2025 · External reference
Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup.
10.1002/alz.13859 · 2024 · External reference
